NIAID Announces Its Withdrawal as a Sponsor of RFA-GM-08-002, Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) [R01]

Notice Number: NOT-AI-07-044

Key Dates
Release Date:  September 13, 2007

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

NIAID has decided to withdraw as a co-sponsor of RFA-GM-08-002 (http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-08-002.html).

 All other aspects of the RFA remain unchanged incluing the sponsorship by:
National Institute of General Medical Sciences (NIGMS),
National Institute on Drug Abuse (NIDA),
National Institute of Mental Health (NIMH),
National Institute of Neurological Disorders and Stroke

Due to the substantial preliminary interest communicated by numerous investigators in widely disparate fields of research versus the limited new funds projected to be available  for this initiative, NIAID has determined that investigators interested in support from NIAID would be much better served, and are likely to have a higher ultimate success rate, by applying for unsolicited R01 grants in response to the Research Project Grant (R01) parent announcement that can be found at http://grants.nih.gov/grants/guide/pa-files/PA-07-070.html .  The NIAID remains committed to considering one award for up to $400,000 to a EUREKA application responsive to the NIGMS research scope and programmatically important to NIAID.

We apologize for any inconvenience we may have caused investigators.

Inquiries

For additional information, please contact:

Allan Czarra
Deputy Director, DEA, NIAID, NIH, DHHS
6700B Rockledge Drive, Room 2140
Bethesda, MD 20892-7610
For express deliveries, use ZIP20817-7610
Phone: 301-496-3772
FAX: 301-402-0369
E-mail: [email protected]